Nuveen’s Abbott ABT Stock Holding History

Nuveen’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-43,800	Closed	-$3K	–	3267
2020 Q1	$3K	Buy	+43,800	New	+$3.65M	﹤0.01%	3169

Other funds holding ABT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Nuveen's ABT Position: Q2 2026 in Review

Nuveen reduced its Abbott (ABT) stake by 12% in Q2 2026, selling an estimated $120M and leaving 9,876,345 shares worth $896M. The position accounts for 0.21% of the portfolio, ranked #86.

Nuveen first reported a position in ABT in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.66B in Q2 2025. 2,981 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

Nuveen held 9,876,345 shares of Abbott worth $896M as of Q2 2026.
Nuveen sold 1,315,508 Abbott shares in Q2 2026, an estimated $120M.
Abbott made up 0.21% of Nuveen's portfolio in Q2 2026, its #86 holding.
Nuveen first reported a position in Abbott in Q2 2013 and has held it in 53 quarters since.
Nuveen's Abbott position peaked at $1.66B in Q2 2025.
2,981 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.